Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 1/20 | 0.31 |
| ▸ | FEN1 | P39748 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1028460 | 0.85 | ALOX5AP (0.32) | ALOX5APFEN1MEN1CYP1A2CYP2C9 | |
| SCHEMBL4167882 | 0.84 | CYP1A2 (0.31) | ALOX5APFEN1MEN1CYP1A2CYP2C9 | |
| SCHEMBL4170216 | 0.82 | ALOX5AP (0.31) | ALOX5APFEN1MEN1CYP1A2CYP2C9 | |
| SCHEMBL3753144 | 0.77 | KMT2A (0.33) | ALOX5APFEN1MEN1CYP1A2CYP2C9 | |
| SCHEMBL5374117 | 0.77 | ALOX5AP (0.33) | ALOX5APFEN1MEN1CYP1A2CYP2C9 | |
| SCHEMBL4171199 | 0.74 | MAPK1 (0.34) | ALOX5APFEN1 | |
| SCHEMBL4216676 | 0.73 | ALOX5AP (0.33) | ALOX5APFEN1MEN1CYP1A2CYP2C9 | |
| SCHEMBL3158849 | 0.73 | GAA (0.32) | ALOX5APFEN1 | |
| SCHEMBL537532 | 0.73 | SMN1; SMN2 (0.35) | ALOX5APFEN1MEN1CYP1A2CYP2C9 | |
| SCHEMBL4173053 | 0.72 | ALOX5AP (0.34) | ALOX5APFEN1MEN1CYP1A2CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090048112-A1 | Novel Herbicides | SYNGENTA LIMITED (GB) | 2009-02-19 | — | — | US | disclosed |
| US-20090042726-A1 | Novel Herbicides | SYNGENTA LIMITED (GB) | 2009-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090048112-A1 | Novel Herbicides | HAX1, MTX1, CYP4X1 | ALOX5AP 4311/4885FEN1 2128/4885MEN1 1520/4885 |
| US-20090042726-A1 | Novel Herbicides | DDT, CBR3, CBR1 | ALOX5AP 2544/4885FEN1 2600/4885MEN1 3398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.